These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32852548)

  • 21. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas.
    Kovatchev BP; Renard E; Cobelli C; Zisser HC; Keith-Hynes P; Anderson SM; Brown SA; Chernavvsky DR; Breton MD; Mize LB; Farret A; Place J; Bruttomesso D; Del Favero S; Boscari F; Galasso S; Avogaro A; Magni L; Di Palma F; Toffanin C; Messori M; Dassau E; Doyle FJ
    Diabetes Care; 2014 Jul; 37(7):1789-96. PubMed ID: 24929429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
    Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.
    Harvey RA; Dassau E; Bevier WC; Seborg DE; Jovanovič L; Doyle FJ; Zisser HC
    Diabetes Technol Ther; 2014 Jun; 16(6):348-57. PubMed ID: 24471561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
    Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
    Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D
    Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.
    Schmidt S; Boiroux D; Duun-Henriksen AK; Frøssing L; Skyggebjerg O; Jørgensen JB; Poulsen NK; Madsen H; Madsbad S; Nørgaard K
    J Diabetes Sci Technol; 2013 Sep; 7(5):1255-64. PubMed ID: 24124952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.
    Luijf YM; DeVries JH; Zwinderman K; Leelarathna L; Nodale M; Caldwell K; Kumareswaran K; Elleri D; Allen JM; Wilinska ME; Evans ML; Hovorka R; Doll W; Ellmerer M; Mader JK; Renard E; Place J; Farret A; Cobelli C; Del Favero S; Dalla Man C; Avogaro A; Bruttomesso D; Filippi A; Scotton R; Magni L; Lanzola G; Di Palma F; Soru P; Toffanin C; De Nicolao G; Arnolds S; Benesch C; Heinemann L;
    Diabetes Care; 2013 Dec; 36(12):3882-7. PubMed ID: 24170747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
    Pinsker JE; Lee JB; Dassau E; Seborg DE; Bradley PK; Gondhalekar R; Bevier WC; Huyett L; Zisser HC; Doyle FJ
    Diabetes Care; 2016 Jul; 39(7):1135-42. PubMed ID: 27289127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and performance of a hybrid closed-loop insulin delivery system with carbohydrate suggestion in adults with type 1 diabetes prone to hypoglycemia.
    Mesa A; Beneyto A; Martín-SanJosé JF; Viaplana J; Bondia J; Vehí J; Conget I; Giménez M
    Diabetes Res Clin Pract; 2023 Nov; 205():110956. PubMed ID: 37844798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System.
    Shalit R; Minsky N; Laron-Hirsh M; Cohen O; Kurtz N; Roy A; Grosman B; Benedetti A; Tirosh A
    Diabetes Technol Ther; 2023 Sep; 25(9):579-588. PubMed ID: 37335759
    [No Abstract]   [Full Text] [Related]  

  • 35. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
    Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
    [No Abstract]   [Full Text] [Related]  

  • 40. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
    DeBoer MD; Breton MD; Wakeman C; Schertz EM; Emory EG; Robic JL; Kollar LL; Kovatchev BP; Cherñavvsky DR
    Diabetes Technol Ther; 2017 May; 19(5):293-298. PubMed ID: 28426239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.